Development of a reporter gene-based assay for the bioactivity determination of rhLH pharmaceutical products

Anal Biochem. 2023 Nov 29;686:115413. doi: 10.1016/j.ab.2023.115413. Online ahead of print.ABSTRACTTo establish an in vitro biological activity detection method for luteinizing hormone (LH), the hLHCGR-CREB-HEK293 cell line was constructed to stably express human luteinizing hormone/chorionic gonadotropin receptor (hLHCGR). After optimization, the rhLH starting working concentration was 800 mIU/mL with 4-fold serial dilutions, 10 concentrations and an incubation time of 5 h. The method was confirmed to be highly specific, with good accuracy, precision and linearity, meeting the needs of process research and release testing, and can be used as a routine detection method for LH biological activity. With the increasing demand for research and development of rhLH biologically similar drugs, establishing a stable and simple activity assay method to evaluate the biological activity of rhLH can provide technical support for quality control of rhLH products and powerful tools for comparability research of similar products.PMID:38040174 | DOI:10.1016/j.ab.2023.115413
Source: Analytical Biochemistry - Category: Biochemistry Authors: Source Type: research